Travaux scientifiques

Prof. Dr. Meral Beksaç

912 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Apoptosis in the haematopoietic stem cell products obtained by continuous flow apheresis method in allogeneic peripheral stem cell transplantation

    Bone Marrow Transplantation, 2004

    Source : ORCID

  2. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival

    Leukemia and Lymphoma, 2004

    DOI 10.1080/1042819032000159915 PMID 15359999 52 citations (Europe PMC) Source : ORCID

  3. Both higher level of (bcr,abl) transcripts and high Hasford risk score are associated with cytogenetic response but absence of molecular remission during first line use of imatinib mesilate(IM): A finding not observed following use among interferon failures

    Blood, 2004

    Source : ORCID

  4. Case-controlled comparative analysis of ablative and reduced-intensity allogeneic haematopoietic stem cell transplantation in standard risk CML

    Bone Marrow Transplantation, 2004

    Source : ORCID

  5. Does donor/recipient parity have any impact on graft-versus-host disease? The results of a single-centre retrospective multivariate analysis

    Bone Marrow Transplantation, 2004

    Source : ORCID

  6. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

    Transfusion and Apheresis Science, 2004

    DOI 10.1016/j.transci.2004.02.003 PMID 15172621 32 citations (Europe PMC) Source : ORCID

  7. Factors influencing the outcome of HLA-identical sibling transplants for chronic myeloid leukaemia: collaborative analysis from three centres in Poland and Turkey

    Bone Marrow Transplantation, 2004

    Source : ORCID

  8. High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre

    Bone Marrow Transplantation, 2004

    Source : ORCID

  9. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

    Journal of Viral Hepatitis, 2004

    DOI 10.1046/j.1365-2893.2003.00479.x PMID 14996349 60 citations (Europe PMC) Source : ORCID

  10. Occurrence of cytomegalovirus infection and/or viraemia shortens overall survival

    Bone Marrow Transplantation, 2004

    Source : ORCID

  11. The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation

    Blood, 2004

    Source : ORCID

  12. The impact of HLA-dr antigens on chronic graft-versus-host disease associated oral lichenoid lesions

    Bone Marrow Transplantation, 2004

    Source : ORCID

  13. The outcome of patients with an identified HLA identical sibling donor:: impact of transplantation rate on early transplant outcome

    Bone Marrow Transplantation, 2004

    Source : ORCID

  14. The use of low molecular weight heparins (dalteparin) for prophylaxis against thromboembolic complications during allogeneic haematopoetic stem cell transplantation

    Bone Marrow Transplantation, 2004

    Source : ORCID

  15. Akut Miyeloid Lösemi

    2004

    Source : OpenAlex

  16. A retrospective comparison of oral versus intravenous administration of busulfan

    Bone Marrow Transplantation, 2003

    Source : ORCID

  17. Allogeneic Hematopoietic Stem Cell Transplantation in chronic myelogenous leukemia: Comparison of ablative and reduced intensity conditioning regimen

    Blood, 2003

    Source : ORCID

  18. Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy

    Turkish Journal of Haematology, 2003

    PMID 27263520 1 citation (OpenAlex) Source : ORCID

  19. Comparative analysis of molecular response following interferon-alpha, imatinib mesilate or allogeneic stem cell transplantation (ASCT): best response is obtained with ASCT in chronic myeloid leukemia

    Bone Marrow Transplantation, 2003

    Source : ORCID

  20. Comparison of mobilized peripheral blood progenitor cells and bone marrow transplantation to HLA-identical siblings with standard-risk leukaemia: long term follow-up

    Bone Marrow Transplantation, 2003

    Source : ORCID

  21. Comparison of three conditioning regimens used in high-dose therapy of malign lymphomas: CBV-ICE-CTM

    Bone Marrow Transplantation, 2003

    Source : ORCID

  22. Differences between graft product and donor side effects following bone marrow or stem cell donation

    Bone Marrow Transplantation, 2003

    DOI 10.1038/sj.bmt.1704245 PMID 14561987 69 citations (Europe PMC) Source : ORCID

  23. Donor type epithelial cell repopulation in gastrointestinal mucosa following sex mismatch allogeneic peripheral blood transplantation: evidence for in vivo stem cell plasticity?

    Bone Marrow Transplantation, 2003

    Source : ORCID

  24. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease:: Turkish experience

    Bone Marrow Transplantation, 2003

    Source : ORCID

  25. Fetal-obstetric parameters that decrease volume (V) or mononuclear cell content (MNC) do not influence total hematopoietic cell content (HSCC) in the cord blood (CB) harvest

    Blood, 2003

    Source : ORCID

  26. Hyperkeratosis of the Nipple Associated with Chronic Graft versus Host Disease after Allogeneic Haematopoietic Cell Transplantation [8]

    Acta Dermato-Venereologica, 2003

    DOI 10.1080/00015550310012665 PMID 14609115 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  27. In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA)

    Blood, 2003

    Source : ORCID

  28. Kinetics of chimerism in sex-mismatched allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

    Bone Marrow Transplantation, 2003

    Source : ORCID

  29. Long-term evaluation of hematopoietic and immune reconstitution following allogeneic peripheral blood hematopoietic cell transplantation during graft-versus-host disease

    Bone Marrow Transplantation, 2003

    Source : ORCID

  30. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, 2003

    DOI 10.1182/blood-2003-03-0665 PMID 12829583 42 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  31. Reduction of stem cell content is a feasible approach in standard risk HLA identical sibling allogeneic peripheral or marrow transplants

    Bone Marrow Transplantation, 2003

    Source : ORCID

  32. Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

    Bone Marrow Transplantation, 2003

    DOI 10.1038/sj.bmt.1703930 PMID 12748666 2 citations (Europe PMC) Source : ORCID

  33. The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia

    Leukemia and Lymphoma, 2003

    DOI 10.1080/1042819031000067512 PMID 12802915 6 citations (Europe PMC) Source : ORCID

  34. The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation

    Bone Marrow Transplantation, 2003

    Source : ORCID

  35. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

    Journal of Hepatology, 2003

    DOI 10.1016/s0168-8278(03)80768-7 Source : ORCID

  36. The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease

    Bone Marrow Transplantation, 2003

    Source : ORCID

  37. The highest doses of alkylating agents administered during hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2003

    Source : ORCID

  38. The relation between T-helper subsets and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2003

    Source : ORCID

  39. Tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta) and interferon-gamma (INF-gamma) polymorphic single nucleotide allele frequencies in patients with multiple myeloma (MM): Disparities between the siblings and effect on treatment outcome

    Blood, 2003

    Source : ORCID

  40. Feature extraction and classification of blood cells for an automated differential blood count system

    International Joint Conference on Neural Networks (IJCNN), 2002

    DOI 10.1109/ijcnn.2001.938753 72 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. A retrospective comparison of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse

    Bone Marrow Transplantation, 2002

    Source : ORCID

  42. Analysis of high and low risk chronic myeloid leukemia by gene expression profiling

    Blood, 2002

    Source : ORCID

  43. Does donor recipient ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation?

    Bone Marrow Transplantation, 2002

    Source : ORCID

  44. Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma

    Turkish Journal of Haematology, 2002

    PMID 27264980 1 citation (OpenAlex) Source : ORCID

  45. HLA-A1 is associated with CMV viremia in recipients of hematopoietic stem cell transplants from seropositive donors

    Tissue Antigens, 2002

    Source : ORCID

  46. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

    Medical Oncology, 2002

    DOI 10.1385/mo:19:1:59 PMID 12025892 6 citations (Europe PMC) Source : ORCID

  47. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers

    Therapeutic Apheresis, 2002

    DOI 10.1046/j.1526-0968.2002.00319.x PMID 11886581 4 citations (Europe PMC) Source : ORCID

  48. Is there a correlation between peripheral blood CD34+cells and peripheral blood erythrocyte precursors in healthy G-CSF stimulated donors and the effect of G-CSF and apheresis on complete blood count

    Bone Marrow Transplantation, 2002

    Source : ORCID

  49. Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans

    Bone Marrow Transplantation, 2002

    Source : ORCID

  50. Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation.: A single institutional experience

    Blood, 2002

    Source : ORCID